http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 24 Jul 2026 16:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/LifeMD+to+Report+Second+Quarter+2026+Financial+Results+on+August+5/26813519.html <p>NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- <strong>LifeMD, Inc. (Nasdaq: LFMD)</strong>, a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on August 5, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.</p> <p><strong>Conference Call &amp; Webcast Details</strong></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:25%; width:25%; min-width:25%;;vertical-align: top ; ">Date:</td><td style="max-width:75%; width:75%; min-width:75%;;vertical-align: top ; ">Wednesday, August 5th</td></tr><tr><td style="vertical-align: top ; ">Time:</td><td style="vertical-align: top ; ">4:30 p.m. Eastern time</td></tr><tr><td http://www.streetinsider.com/Press+Releases/LifeMD+to+Report+Second+Quarter+2026+Financial+Results+on+August+5/26813519.html Fri, 24 Jul 2026 16:05:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/Press+Releases/LifeMD+to+Report+Second+Quarter+2026+Financial+Results+on+August+5/26813519.html <p>NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- <strong>LifeMD, Inc. (Nasdaq: LFMD)</strong>, a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on August 5, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.</p> <p><strong>Conference Call &amp; Webcast Details</strong></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:25%; width:25%; min-width:25%;;vertical-align: top ; ">Date:</td><td style="max-width:75%; width:75%; min-width:75%;;vertical-align: top ; ">Wednesday, August 5th</td></tr><tr><td style="vertical-align: top ; ">Time:</td><td style="vertical-align: top ; ">4:30 p.m. Eastern time</td></tr><tr><td http://www.streetinsider.com/Press+Releases/LifeMD+to+Report+Second+Quarter+2026+Financial+Results+on+August+5/26813519.html Fri, 24 Jul 2026 16:05:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/Press+Releases/LifeMD+to+Report+Second+Quarter+2026+Financial+Results+on+August+5/26813519.html <p>NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- <strong>LifeMD, Inc. (Nasdaq: LFMD)</strong>, a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on August 5, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.</p> <p><strong>Conference Call &amp; Webcast Details</strong></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:25%; width:25%; min-width:25%;;vertical-align: top ; ">Date:</td><td style="max-width:75%; width:75%; min-width:75%;;vertical-align: top ; ">Wednesday, August 5th</td></tr><tr><td style="vertical-align: top ; ">Time:</td><td style="vertical-align: top ; ">4:30 p.m. Eastern time</td></tr><tr><td http://www.streetinsider.com/Press+Releases/LifeMD+to+Report+Second+Quarter+2026+Financial+Results+on+August+5/26813519.html Fri, 24 Jul 2026 16:05:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/Globe+Newswire/LifeMD+to+Report+Second+Quarter+2026+Financial+Results+on+August+5/26813519.html <p>NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- <strong>LifeMD, Inc. (Nasdaq: LFMD)</strong>, a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on August 5, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.</p> <p><strong>Conference Call &amp; Webcast Details</strong></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:25%; width:25%; min-width:25%;;vertical-align: top ; ">Date:</td><td style="max-width:75%; width:75%; min-width:75%;;vertical-align: top ; ">Wednesday, August 5th</td></tr><tr><td style="vertical-align: top ; ">Time:</td><td style="vertical-align: top ; ">4:30 p.m. Eastern time</td></tr><tr><td http://www.streetinsider.com/Globe+Newswire/LifeMD+to+Report+Second+Quarter+2026+Financial+Results+on+August+5/26813519.html Fri, 24 Jul 2026 16:05:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/Globe+Newswire/LifeMD+to+Report+Second+Quarter+2026+Financial+Results+on+August+5/26813519.html <p>NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- <strong>LifeMD, Inc. (Nasdaq: LFMD)</strong>, a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on August 5, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.</p> <p><strong>Conference Call &amp; Webcast Details</strong></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:25%; width:25%; min-width:25%;;vertical-align: top ; ">Date:</td><td style="max-width:75%; width:75%; min-width:75%;;vertical-align: top ; ">Wednesday, August 5th</td></tr><tr><td style="vertical-align: top ; ">Time:</td><td style="vertical-align: top ; ">4:30 p.m. Eastern time</td></tr><tr><td http://www.streetinsider.com/Globe+Newswire/LifeMD+to+Report+Second+Quarter+2026+Financial+Results+on+August+5/26813519.html Fri, 24 Jul 2026 16:05:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/Globe+Newswire/LifeMD+to+Report+Second+Quarter+2026+Financial+Results+on+August+5/26813519.html <p>NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- <strong>LifeMD, Inc. (Nasdaq: LFMD)</strong>, a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on August 5, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.</p> <p><strong>Conference Call &amp; Webcast Details</strong></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:25%; width:25%; min-width:25%;;vertical-align: top ; ">Date:</td><td style="max-width:75%; width:75%; min-width:75%;;vertical-align: top ; ">Wednesday, August 5th</td></tr><tr><td style="vertical-align: top ; ">Time:</td><td style="vertical-align: top ; ">4:30 p.m. Eastern time</td></tr><tr><td http://www.streetinsider.com/Globe+Newswire/LifeMD+to+Report+Second+Quarter+2026+Financial+Results+on+August+5/26813519.html Fri, 24 Jul 2026 16:05:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++LifeMD%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+FEDERATED+HERMES%2C+INC./26744344.html si-local-file:///var/storage/secattach/20260708/26744344.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++LifeMD%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+FEDERATED+HERMES%2C+INC./26744344.html Wed, 08 Jul 2026 07:45:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++LifeMD%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+FEDERATED+HERMES%2C+INC./26744344.html si-local-file:///var/storage/secattach/20260708/26744344.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++LifeMD%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+FEDERATED+HERMES%2C+INC./26744344.html Wed, 08 Jul 2026 07:45:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++LifeMD%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+FEDERATED+HERMES%2C+INC./26744344.html si-local-file:///var/storage/secattach/20260708/26744344.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++LifeMD%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+FEDERATED+HERMES%2C+INC./26744344.html Wed, 08 Jul 2026 07:45:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/Press+Releases/LifeMD+Declares+Quarterly+Dividend+on+Series+A+Cumulative+Perpetual+Preferred+Stock/26676206.html <p align="justify">NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=NXUAdf4tlmeBCtXumNPrs2zipyjnKwpbSgj49JO4QmkDDpAKSvVBMCpPk8Hi8jZxqDYPvYIYl5N4lCYLx0hrOQ==" rel="nofollow" target="_blank">LifeMD, Inc.</a> (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.</p> <p align="justify">The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.</p> <p align="justify"><strong>About LifeMD, Inc.</strong></p> <p align="justify">LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access http://www.streetinsider.com/Press+Releases/LifeMD+Declares+Quarterly+Dividend+on+Series+A+Cumulative+Perpetual+Preferred+Stock/26676206.html Tue, 23 Jun 2026 08:00:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/Press+Releases/LifeMD+Declares+Quarterly+Dividend+on+Series+A+Cumulative+Perpetual+Preferred+Stock/26676206.html <p align="justify">NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=NXUAdf4tlmeBCtXumNPrs2zipyjnKwpbSgj49JO4QmkDDpAKSvVBMCpPk8Hi8jZxqDYPvYIYl5N4lCYLx0hrOQ==" rel="nofollow" target="_blank">LifeMD, Inc.</a> (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.</p> <p align="justify">The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.</p> <p align="justify"><strong>About LifeMD, Inc.</strong></p> <p align="justify">LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access http://www.streetinsider.com/Press+Releases/LifeMD+Declares+Quarterly+Dividend+on+Series+A+Cumulative+Perpetual+Preferred+Stock/26676206.html Tue, 23 Jun 2026 08:00:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/Press+Releases/LifeMD+Declares+Quarterly+Dividend+on+Series+A+Cumulative+Perpetual+Preferred+Stock/26676206.html <p align="justify">NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=NXUAdf4tlmeBCtXumNPrs2zipyjnKwpbSgj49JO4QmkDDpAKSvVBMCpPk8Hi8jZxqDYPvYIYl5N4lCYLx0hrOQ==" rel="nofollow" target="_blank">LifeMD, Inc.</a> (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.</p> <p align="justify">The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.</p> <p align="justify"><strong>About LifeMD, Inc.</strong></p> <p align="justify">LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access http://www.streetinsider.com/Press+Releases/LifeMD+Declares+Quarterly+Dividend+on+Series+A+Cumulative+Perpetual+Preferred+Stock/26676206.html Tue, 23 Jun 2026 08:00:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/Globe+Newswire/LifeMD+Declares+Quarterly+Dividend+on+Series+A+Cumulative+Perpetual+Preferred+Stock/26676206.html <p align="justify">NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=NXUAdf4tlmeBCtXumNPrs2zipyjnKwpbSgj49JO4QmkDDpAKSvVBMCpPk8Hi8jZxqDYPvYIYl5N4lCYLx0hrOQ==" rel="nofollow" target="_blank">LifeMD, Inc.</a> (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.</p> <p align="justify">The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.</p> <p align="justify"><strong>About LifeMD, Inc.</strong></p> <p align="justify">LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access http://www.streetinsider.com/Globe+Newswire/LifeMD+Declares+Quarterly+Dividend+on+Series+A+Cumulative+Perpetual+Preferred+Stock/26676206.html Tue, 23 Jun 2026 08:00:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/Globe+Newswire/LifeMD+Declares+Quarterly+Dividend+on+Series+A+Cumulative+Perpetual+Preferred+Stock/26676206.html <p align="justify">NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=NXUAdf4tlmeBCtXumNPrs2zipyjnKwpbSgj49JO4QmkDDpAKSvVBMCpPk8Hi8jZxqDYPvYIYl5N4lCYLx0hrOQ==" rel="nofollow" target="_blank">LifeMD, Inc.</a> (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.</p> <p align="justify">The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.</p> <p align="justify"><strong>About LifeMD, Inc.</strong></p> <p align="justify">LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access http://www.streetinsider.com/Globe+Newswire/LifeMD+Declares+Quarterly+Dividend+on+Series+A+Cumulative+Perpetual+Preferred+Stock/26676206.html Tue, 23 Jun 2026 08:00:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/Globe+Newswire/LifeMD+Declares+Quarterly+Dividend+on+Series+A+Cumulative+Perpetual+Preferred+Stock/26676206.html <p align="justify">NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=NXUAdf4tlmeBCtXumNPrs2zipyjnKwpbSgj49JO4QmkDDpAKSvVBMCpPk8Hi8jZxqDYPvYIYl5N4lCYLx0hrOQ==" rel="nofollow" target="_blank">LifeMD, Inc.</a> (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.</p> <p align="justify">The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.</p> <p align="justify"><strong>About LifeMD, Inc.</strong></p> <p align="justify">LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access http://www.streetinsider.com/Globe+Newswire/LifeMD+Declares+Quarterly+Dividend+on+Series+A+Cumulative+Perpetual+Preferred+Stock/26676206.html Tue, 23 Jun 2026 08:00:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LifeMD%2C+Inc.++++++++++++++For%3A+Jun+22/26670355.html si-local-file:///var/storage/secattach/20260622/26670355.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LifeMD%2C+Inc.++++++++++++++For%3A+Jun+22/26670355.html Mon, 22 Jun 2026 08:26:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LifeMD%2C+Inc.++++++++++++++For%3A+Jun+22/26670355.html si-local-file:///var/storage/secattach/20260622/26670355.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LifeMD%2C+Inc.++++++++++++++For%3A+Jun+22/26670355.html Mon, 22 Jun 2026 08:26:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LifeMD%2C+Inc.++++++++++++++For%3A+Jun+22/26670355.html si-local-file:///var/storage/secattach/20260622/26670355.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LifeMD%2C+Inc.++++++++++++++For%3A+Jun+22/26670355.html Mon, 22 Jun 2026 08:26:00 -0400 LFMD LFMDP O.09946953 http://www.streetinsider.com/Corporate+News/LifeMD+to+launch+self-pay+testosterone+program+with+Antares+Pharma/26670178.html <p>LifeMD, Inc. (Nasdaq: LFMD) announced an exclusive co-marketing agreement with Antares Pharma, Inc., a wholly owned subsidiary of Halozyme, to support a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate) injection, an FDA-approved once-weekly subcutaneous testosterone auto-injector.</p><p>The program is scheduled to launch in July 2026 and will initially be available in 37 states. Under the arrangement, LifeMD will serve as the exclusive telehealth co-marketing partner, with patient evaluations conducted through LifeMD's affiliated medical group and XYOSTED dispensed through LifeMD's pharmacy and shipped directly to patients' homes.</p><p>The self-pay program is priced at approximately $249 per month, covering both medication and clinical care http://www.streetinsider.com/Corporate+News/LifeMD+to+launch+self-pay+testosterone+program+with+Antares+Pharma/26670178.html Mon, 22 Jun 2026 08:01:18 -0400 LFMD LFMDP http://www.streetinsider.com/Corporate+News/LifeMD+to+launch+self-pay+testosterone+program+with+Antares+Pharma/26670178.html <p>LifeMD, Inc. (Nasdaq: LFMD) announced an exclusive co-marketing agreement with Antares Pharma, Inc., a wholly owned subsidiary of Halozyme, to support a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate) injection, an FDA-approved once-weekly subcutaneous testosterone auto-injector.</p><p>The program is scheduled to launch in July 2026 and will initially be available in 37 states. Under the arrangement, LifeMD will serve as the exclusive telehealth co-marketing partner, with patient evaluations conducted through LifeMD's affiliated medical group and XYOSTED dispensed through LifeMD's pharmacy and shipped directly to patients' homes.</p><p>The self-pay program is priced at approximately $249 per month, covering both medication and clinical care http://www.streetinsider.com/Corporate+News/LifeMD+to+launch+self-pay+testosterone+program+with+Antares+Pharma/26670178.html Mon, 22 Jun 2026 08:01:18 -0400 LFMD LFMDP http://www.streetinsider.com/Press+Releases/LifeMD+Announces+Exclusive+Collaboration+to+Launch+Direct-to-Patient+Self-Pay+Program+for+XYOSTED%C2%AE+%28testosterone+enanthate%29+Injection/26670064.html <p><em>Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, launching in July 2026 in 37 states</em></p> <p><em>Companies to collaborate on consumer education and promotional initiatives to expand awareness of hypogonadism and convenient, transparent access to FDA-approved treatment</em></p> <p>NEW YORK and SAN DIEGO, June 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and specialty care today announced a strategic co-marketing collaboration supporting a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate) injection, the only http://www.streetinsider.com/Press+Releases/LifeMD+Announces+Exclusive+Collaboration+to+Launch+Direct-to-Patient+Self-Pay+Program+for+XYOSTED%C2%AE+%28testosterone+enanthate%29+Injection/26670064.html Mon, 22 Jun 2026 08:00:00 -0400 A.15159508 A.30035300 LFMD LFMDP O.00649154 O.09946953 O.20947283 http://www.streetinsider.com/Press+Releases/LifeMD+Announces+Exclusive+Collaboration+to+Launch+Direct-to-Patient+Self-Pay+Program+for+XYOSTED%C2%AE+%28testosterone+enanthate%29+Injection/26670064.html <p><em>Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, launching in July 2026 in 37 states</em></p> <p><em>Companies to collaborate on consumer education and promotional initiatives to expand awareness of hypogonadism and convenient, transparent access to FDA-approved treatment</em></p> <p>NEW YORK and SAN DIEGO, June 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and specialty care today announced a strategic co-marketing collaboration supporting a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate) injection, the only http://www.streetinsider.com/Press+Releases/LifeMD+Announces+Exclusive+Collaboration+to+Launch+Direct-to-Patient+Self-Pay+Program+for+XYOSTED%C2%AE+%28testosterone+enanthate%29+Injection/26670064.html Mon, 22 Jun 2026 08:00:00 -0400 A.15159508 A.30035300 LFMD LFMDP O.00649154 O.09946953 O.20947283 http://www.streetinsider.com/Press+Releases/LifeMD+Announces+Exclusive+Collaboration+to+Launch+Direct-to-Patient+Self-Pay+Program+for+XYOSTED%C2%AE+%28testosterone+enanthate%29+Injection/26670064.html <p><em>Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, launching in July 2026 in 37 states</em></p> <p><em>Companies to collaborate on consumer education and promotional initiatives to expand awareness of hypogonadism and convenient, transparent access to FDA-approved treatment</em></p> <p>NEW YORK and SAN DIEGO, June 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and specialty care today announced a strategic co-marketing collaboration supporting a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate) injection, the only http://www.streetinsider.com/Press+Releases/LifeMD+Announces+Exclusive+Collaboration+to+Launch+Direct-to-Patient+Self-Pay+Program+for+XYOSTED%C2%AE+%28testosterone+enanthate%29+Injection/26670064.html Mon, 22 Jun 2026 08:00:00 -0400 A.15159508 A.30035300 LFMD LFMDP O.00649154 O.09946953 O.20947283 http://www.streetinsider.com/Press+Releases/LifeMD+Announces+Exclusive+Collaboration+to+Launch+Direct-to-Patient+Self-Pay+Program+for+XYOSTED%C2%AE+%28testosterone+enanthate%29+Injection/26670064.html <p><em>Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, launching in July 2026 in 37 states</em></p> <p><em>Companies to collaborate on consumer education and promotional initiatives to expand awareness of hypogonadism and convenient, transparent access to FDA-approved treatment</em></p> <p>NEW YORK and SAN DIEGO, June 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and specialty care today announced a strategic co-marketing collaboration supporting a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate) injection, the only http://www.streetinsider.com/Press+Releases/LifeMD+Announces+Exclusive+Collaboration+to+Launch+Direct-to-Patient+Self-Pay+Program+for+XYOSTED%C2%AE+%28testosterone+enanthate%29+Injection/26670064.html Mon, 22 Jun 2026 08:00:00 -0400 A.15159508 A.30035300 LFMD LFMDP O.00649154 O.09946953 O.20947283 http://www.streetinsider.com/Press+Releases/LifeMD+Announces+Exclusive+Collaboration+to+Launch+Direct-to-Patient+Self-Pay+Program+for+XYOSTED%C2%AE+%28testosterone+enanthate%29+Injection/26670064.html <p><em>Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, launching in July 2026 in 37 states</em></p> <p><em>Companies to collaborate on consumer education and promotional initiatives to expand awareness of hypogonadism and convenient, transparent access to FDA-approved treatment</em></p> <p>NEW YORK and SAN DIEGO, June 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and specialty care today announced a strategic co-marketing collaboration supporting a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate) injection, the only http://www.streetinsider.com/Press+Releases/LifeMD+Announces+Exclusive+Collaboration+to+Launch+Direct-to-Patient+Self-Pay+Program+for+XYOSTED%C2%AE+%28testosterone+enanthate%29+Injection/26670064.html Mon, 22 Jun 2026 08:00:00 -0400 A.15159508 A.30035300 LFMD LFMDP O.00649154 O.09946953 O.20947283